A

AtriCure
D

ATRC

30.020
USD
0.72
(2.46%)
مغلق
حجم التداول
34,263
الربح لكل سهم
-0
العائد الربحي
-
P/E
-37
حجم السوق
1,486,135,627
أصول ذات صلة
ABT
ABT
1.930
(1.47%)
132.820 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
BSX
BSX
1.730
(1.68%)
104.900 USD
EW
EW
0.480
(0.64%)
75.650 USD
ISRG
ISRG
12.25
(2.37%)
529.20 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
MDT
MDT
1.280
(1.53%)
84.850 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
RMD
RMD
3.440
(1.45%)
239.905 USD
SYK
SYK
4.11
(1.10%)
378.26 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
المزيد
الأخبار المقالات

العنوان: AtriCure

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct salesforce and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.